Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses Through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia

Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2018.00009